We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+15%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$298M
AUM Growth
+$36.1M
Cap. Flow
-$1.63M
Cap. Flow %
-0.55%
Top 10 Hldgs %
50.06%
Holding
56
New
4
Increased
19
Reduced
20
Closed
1

Top Buys

Rank Stock Value
1
OMCL icon
Omnicell
OMCL
+$6M
2
NVRO
NEVRO CORP.
NVRO
+$4.76M
3
NKTR icon
Nektar Therapeutics
NKTR
+$4.75M
4
SHPG
Shire pic
SHPG
+$2.4M
5
ENTL
Entellus Medical, Inc. Common Stock
ENTL
+$1.46M

Top Sells

Rank Stock Value
1
XENT
Intersect ENT, Inc
XENT
+$8.92M
2
ENZ
Enzo Biochem, Inc.
ENZ
+$6.7M
3
HSTM icon
HealthStream
HSTM
+$3.4M
4
LHCG
LHC Group LLC
LHCG
+$2.04M
5
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
+$1.46M

Sector Composition

Rank Sector Weight
1 Healthcare 74.97%
2 Energy 2.09%
3 Communication Services 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECH icon
26
Bio-Techne
TECH
$11.2B
$4.49M 1.51%
152,776
-32
-0% -$875
ENZ
27
DELISTED
Enzo Biochem, Inc.
ENZ
$4.45M 1.49%
403,082
-718,654
-64% -$6.7M
NVRO
28
DELISTED
NEVRO CORP.
NVRO
$4.42M 1.48%
+59,358
New +$4.76M
NXTM
29
DELISTED
NxStage Medical Inc.
NXTM
$4.3M 1.44%
171,578
+1,571
+0.9% +$38.9K
BLUE
30
DELISTED
bluebird bio
BLUE
$3.55M 1.19%
2,608
-1,196
-31% -$1.44M
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$121B
$2.98M 1%
23,119
-6
-0% -$722
BMRN icon
32
BioMarin Pharmaceuticals
BMRN
$11.6B
$2.87M 0.96%
31,567
-25
-0.1% -$2.27K
IBB icon
33
iShares Biotechnology ETF
IBB
$9.34B
$2.2M 0.74%
21,291
– –
IONS icon
34
Ionis Pharmaceuticals
IONS
$8.6B
$2.14M 0.72%
42,015
-8,174
-16% -$381K
QDEL icon
35
QuidelOrtho
QDEL
$1.14B
$2.01M 0.68%
74,201
-182
-0.2% -$4.51K
NSTG
36
DELISTED
NanoString Technologies, Inc.
NSTG
$1.9M 0.64%
114,702
-53
-0% -$936
STRM
37
DELISTED
Streamline Health Solutions
STRM
$1.9M 0.64%
118,103
+9,040
+8% +$166K
CELG
38
DELISTED
Celgene Corp
CELG
$1.78M 0.6%
13,701
– –
ALKS icon
39
Alkermes
ALKS
$8.22B
$1.72M 0.58%
29,700
+11
+0% +$639
XLVS
40
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
$1.52M 0.51%
17,285
– –
CDXS icon
41
Codexis
CDXS
$151M
$1.5M 0.5%
+274,990
New +$1.26M
XLV icon
42
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$1.45M 0.48%
18,241
– –
LMAT icon
43
LeMaitre Vascular
LMAT
$2.32B
$1.44M 0.48%
46,234
+31
+0.1% +$895
IHI icon
44
iShares US Medical Devices ETF
IHI
$3.13B
$1.26M 0.42%
45,480
– –
MGNX icon
45
MacroGenics
MGNX
$235M
$1.08M 0.36%
61,538
+35
+0.1% +$668
IRIX icon
46
IRIDEX
IRIX
$14.3M
$997K 0.33%
+100,830
New +$993K
XBI icon
47
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$733K 0.25%
9,499
– –
TEAR
48
DELISTED
TearLab Corporation
TEAR
$702K 0.24%
420,066
-959
-0.2% -$1.95K
SNY icon
49
Sanofi
SNY
$103B
$322K 0.11%
6,720
– –
ABBV icon
50
AbbVie
ABBV
$443B
$302K 0.1%
4,159
– –
1
2
3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, First Light Asset Management held 56 positions worth $298M, up 14% from $262M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

First Light Asset Management's Q2 2017 filing shows 4 new, 19 increased, 20 reduced and 1 closed positions. Its largest new stake was NEVRO CORP.: 59,358 shares worth $4.42M. The largest sale was Intersect ENT, Inc, an estimated $8.92M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, up from 74% a quarter earlier, followed by Energy and Communication Services.

  • First Light Asset Management's largest Q2 2017 buy was NEVRO CORP.: 59,358 shares worth $4.42M.
  • First Light Asset Management added most to Omnicell in Q2 2017, an estimated $6M increase.
  • First Light Asset Management's biggest Q2 2017 reduction was Intersect ENT, Inc, cutting an estimated $8.92M.
  • First Light Asset Management fully exited Chembio diagnostics, Inc. in Q2 2017, selling an estimated $294K.
  • First Light Asset Management's ten largest holdings make up 50% of its $298M portfolio in Q2 2017.
  • First Light Asset Management opened 4 new positions and closed 1 in Q2 2017.
  • First Light Asset Management's portfolio value rose 14% quarter-over-quarter to $298M.

Based on First Light Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.